[Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
We investigated the relationship between serological grouping of hepatitis C virus and the response to IFN therapy in type C chronic hepatitis. In group I, responders were low (28%) with a high incidence of recurrence of HCV-RNA (72%). By contrast, in group II, responders were high (62%) and recurrence of HCV-RNA (17%) was low. Serological grouping of hepatitis C virus is useful in the prediction of the outcome of IFN therapy in type C chronic hepatitis.